AzTrials
AzTrials

Retinal DetachmentNCT03218371

Scleral Self-indentation Chandelier-assisted Peripheral Vitrectomy Under Air Rhegmatogenous Retinal Detachment.

An observational study of Retinal Detachment, run by Dar El Oyoun Hospital at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators compared the incidence of trimming-induced retinal breaks, retinal redetachment rate, and final LogMAR BCVA; between scleral self-indentation and non-indentation during chandelier-assisted peripheral vitrectomy under air for eyes with primary retinal detachment. Read more about this study

Who is it for?
Ages 16 to 80 years
Conditions the study is for
Retinal Detachment
What is being tested?
chandelier-assisted peripheral vitrectomy under air
Type of treatment
Surgery or procedure
How many people
130 participants
Where
1 siteEgypt
Study dates
Oct 2013to Apr 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 80 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: This is a retrospective cohort study that was done on eyes (participants) with rhegmatogenous retinal detachment (RRD) for whom chandelier-assisted peripheral vitrectomy under air (CPVA) had been performed; whether using scleral self-indentation (Exposure), or without scleral self-indentation (control)

Who may be able to join

  • RRD with postoperative follow up > 3 months, without PVR, or with PVR A-B

Who cannot join

  • RRD with less than 3 months of postoperative follow-up,
  • RRD with proliferative vitreoretinopathy grade C (PVR C),
  • RRD with uveitis,
  • RRD with choroidal detachment,
  • Giant retinal tears,
  • Retinal dialysis,
Show all 10Show fewer
  • Myopic macular hole RRD,
  • Traumatic RD,
  • Children < 16 years old,
  • The later vitrectomy (if vitrectomy had been performed for RRD in both eyes)

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Dareloyoun hospital

    Cairo, 12611

Other trials in Egypt

About this study

Official title: Scleral Self-indentation During Chandelier-assisted Peripheral Vitrectomy Under Air for Rhegmatogenous Retinal Detachment: A Retrospective Cohort Study.

The investigators compared the incidence of trimming-induced retinal breaks, retinal redetachment rate, and final LogMAR BCVA; between scleral self-indentation and non-indentation during chandelier-assisted peripheral vitrectomy under air for eyes with primary retinal detachment. Self-indentation enables complete trimming of the vitreous base without causing iatrogenic retinal breaks, with a higher retinal reattachment rate, and with less need for chandelier shift than with non-indentation approach.

Read the detailed description

Retrospective cohort study. One hundred and thirty eyes of 130 participants with primary rhegmatogenous retinal detachment were identified. All the participants had undergone a chandelier-assisted peripheral vitrectomy under air. Scleral self-indentation had been used in 68 eyes (study group) (Indentation group), while non-indentation had been used in 62 eyes (comparison group) (Non-indentation group). Outcome variables included: Trimming-induced retinal breaks (TIRB), retinal redetachment rate, final LogMAR BCVA, and intraoperative complications.

Being tested
chandelier-assisted peripheral vitrectomy under air
Keywords
scleral indentation, chandelier light, air vitrectomy, rhegmatogenous retinal detachment
Medical subject headings
Retinal Detachment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • chandelier-assisted peripheral vitrectomy under airProcedure or surgery

    chandelier-assisted peripheral vitrectomy under air for management of peripheral vitreous during RD vitrectomy; whether using indentation or non-indentation

Study groups in NCT03218371
Study groupRoleWhat they receive
study group (Indentation)Eyes (participants) for whom chandelier-assisted peripheral vitrectomy under air had been performed with scleral indentation. (Exposure)
Receives: Procedure: chandelier-assisted peripheral vitrectomy under air
control group (Non-indentation)eyes (participants) for whom chandelier-assisted peripheral vitrectomy under air had been performed without scleral indentation.
Receives: Procedure: chandelier-assisted peripheral vitrectomy under air

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Trimming-induced retinal breaks (TIRB) (yes/ No)

    number of eyes with iatrogenic retinal breaks along vitreous base during vitreous base trimming

    Measured: intraoperative

Secondary outcomes (6)
  1. number of Trimming-induced retinal breaks (TIRB)

    number of iatrogenic retinal breaks along vitreous base during vitreous base trimming

    Measured: intraoperative

  2. retinal redetachment rate (yes/no)

    number of eyes in which recurrent retinal detachment occurred

    Measured: within 3 months

  3. final LogMAR BCVA

    best spectacle corrected visual acuity measured by decimal charts then converted to LogMAR

    Measured: final follow-up visit ( at least 3 months)

  4. snellen BCVA > 20/100 (yes/ no)

    number of eyes with best corrected visual acuity better than snellen's 20/100 measured by snellen's chart

    Measured: 3 months

  5. Chandelier shift (yes/no)

    the need to shift position of chandelier light

    Measured: intraoperative

  6. Local anaesthesia augmentation (yes/no)

    the need for augmenting local anesthesia for the participant to tolerate indentation

    Measured: intraoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jul 2017
  2. Study startOct 2013
  3. Primary completionJan 2016
  4. Study completionApr 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
130 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03218371
Sponsor's protocol ID
DEO00001258
Status last verified
Jul 2017
First submitted
7 Jul 2017
Last updated
14 Jul 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Retinal Detachment, run by Dar El Oyoun Hospital at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Jul 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Trimming-induced retinal breaks (TIRB) (yes/ No) (time frame: intraoperative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jul 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in